aTyr Pharma Statistics Share Statistics aTyr Pharma has 89M
shares outstanding. The number of shares has increased by 17.43%
in one year.
Shares Outstanding 89M Shares Change (YoY) 17.43% Shares Change (QoQ) 0.16% Owned by Institutions (%) n/a Shares Floating 86.66M Failed to Deliver (FTD) Shares 2,259 FTD / Avg. Volume 0.06%
Short Selling Information The latest short interest is 20.38M, so 22.9% of the outstanding
shares have been sold short.
Short Interest 20.38M Short % of Shares Out 22.9% Short % of Float 27.94% Short Ratio (days to cover) 5.82
Valuation Ratios The PE ratio is -4.2 and the forward
PE ratio is -8.65.
aTyr Pharma's PEG ratio is
0.49.
PE Ratio -4.2 Forward PE -8.65 PS Ratio 1143.94 Forward PS 20.6 PB Ratio 3.84 P/FCF Ratio -3.89 PEG Ratio 0.49
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for aTyr Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.48,
with a Debt / Equity ratio of 0.19.
Current Ratio 5.48 Quick Ratio 5.48 Debt / Equity 0.19 Debt / EBITDA -0.2 Debt / FCF -0.19 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $4.2K Profits Per Employee $-1.14M Employee Count 56 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 209.94% in the
last 52 weeks. The beta is 0.95, so aTyr Pharma's
price volatility has been higher than the market average.
Beta 0.95 52-Week Price Change 209.94% 50-Day Moving Average 5.31 200-Day Moving Average 3.89 Relative Strength Index (RSI) 49.96 Average Volume (20 Days) 3,921,062
Income Statement In the last 12 months, aTyr Pharma had revenue of 235K
and earned -64.02M
in profits. Earnings per share was -0.86.
Revenue 235K Gross Profit 235K Operating Income -67.91M Net Income -64.02M EBITDA -66.37M EBIT -67.91M Earnings Per Share (EPS) -0.86
Full Income Statement Balance Sheet The company has 11.05M in cash and 13.28M in
debt, giving a net cash position of -2.23M.
Cash & Cash Equivalents 11.05M Total Debt 13.28M Net Cash -2.23M Retained Earnings -532.05M Total Assets 97.25M Working Capital 72.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -69.12M
and capital expenditures -65K, giving a free cash flow of -69.18M.
Operating Cash Flow -69.12M Capital Expenditures -65K Free Cash Flow -69.18M FCF Per Share -0.93
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -28899.57% and -27243.83%.
Gross Margin 100% Operating Margin -28899.57% Pretax Margin -27243.4% Profit Margin -27243.83% EBITDA Margin -28244.26% EBIT Margin -28899.57% FCF Margin -29440%
Dividends & Yields ATYR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ATYR is $16,
which is 185.2% higher than the current price. The consensus rating is "Buy".
Price Target $16 Price Target Difference 185.2% Analyst Consensus Buy Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 1, 2019. It was a
backward
split with a ratio of 1:14.
Last Split Date Jul 1, 2019 Split Type backward Split Ratio 1:14
Scores Altman Z-Score 3.39 Piotroski F-Score 2
